Eye-Care Brand, Others Said In Bid To Buy Majority Of Vasan Healthcare
This article was originally published in PharmAsia News
A group of investors that includes a "global eye-care brand" reportedly is negotiating to buy a majority of Vasan Healthcare, an India operator of eye-care hospitals.
You may also be interested in...
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.
T-knife, a developer of T-cell receptors intended for T-cell therapy in solid tumor cancers, says the series A gives its development program three years of financial runway.